Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG, Jayakumaran G, DuBoff M, Zhang L, Francis JH, Abramson DH, Cercek A, Nash GM, Shoushtari A, Chapman P, D'Angelo S, Arnold AG, Siegel B, Fleischut MH, Ni A, Rimner A, Rusch VW, Adusumilli PS, Travis W, Sauter JL, Zehir A, Mandelker D, Ladanyi M, Robson M. Zauderer MG, et al. Among authors: rimner a. J Thorac Oncol. 2019 Nov;14(11):1989-1994. doi: 10.1016/j.jtho.2019.07.002. Epub 2019 Jul 16. J Thorac Oncol. 2019. PMID: 31323388 Free PMC article.
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rosenzweig KE, Zauderer MG, Laser B, Krug LM, Yorke E, Sima CS, Rimner A, Flores R, Rusch V. Rosenzweig KE, et al. Among authors: rimner a. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1278-83. doi: 10.1016/j.ijrobp.2011.09.027. Epub 2012 May 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22607910 Free PMC article.
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors.
Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, Pietanza MC, Azzoli CG, Rizvi NA, Krug LM, Miller VA, Kris MG, Riely GJ. Yu HA, et al. Among authors: rimner a. J Thorac Oncol. 2013 Mar;8(3):346-51. doi: 10.1097/JTO.0b013e31827e1f83. J Thorac Oncol. 2013. PMID: 23407558 Free PMC article.
Stereotactic body radiation therapy for primary lung cancers >3 centimeters.
Cuaron JJ, Yorke ED, Foster A, Hsu M, Zhang Z, Liu F, Jackson A, Mychalczak B, Rosenzweig KE, Wu AJ, Rimner A. Cuaron JJ, et al. Among authors: rimner a. J Thorac Oncol. 2013 Nov;8(11):1396-401. doi: 10.1097/JTO.0b013e3182a47181. J Thorac Oncol. 2013. PMID: 24077457 Free article.
Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases.
Filosso PL, Yao X, Ahmad U, Zhan Y, Huang J, Ruffini E, Travis W, Lucchi M, Rimner A, Antonicelli A, Guerrera F, Detterbeck F; European Society of Thoracic Surgeons Thymic Group Steering Committee. Filosso PL, et al. Among authors: rimner a. J Thorac Cardiovasc Surg. 2015 Jan;149(1):103-9.e2. doi: 10.1016/j.jtcvs.2014.08.061. Epub 2014 Sep 16. J Thorac Cardiovasc Surg. 2015. PMID: 25308116 Free article.
267 results